Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Repasky

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Melanoma Research|March 7, 2022
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patientsMichael M Wach, John R Subjeck, Xiang-Yang Wang, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunityXiaofei Yu, Wenjie Liu, Shixian Chen, et al.
Research Square|May 19, 2025
An integrated machine learning-based prognostic model in head and neck cancer using the systemic inflammatory response index and correlations with patient reported financial toxicityAnurag Singh, Sung Jun Ma, Dukagjin Blakaj, et al.
Research Square|April 24, 2023
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapyScott Gerber, Taylor Uccello, Maggie Lesch, et al.
JAMA Network Open|April 15, 2022
Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck CancerSung Jun Ma, Han Yu, Michael Khan, et al.
JAMA Network Open|June 27, 2023
Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapySung Jun Ma, Michael Khan, Udit Chatterjee, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
Cell Stress & Chaperones|February 4, 2024
Stress biology: Complexity and multifariousness in health and diseaseMatthias P Mayer, Laura Blair, Gregory L Blatch, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Melanoma Research|March 7, 2022
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patientsMichael M Wach, John R Subjeck, Xiang-Yang Wang, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunityXiaofei Yu, Wenjie Liu, Shixian Chen, et al.
Research Square|May 19, 2025
An integrated machine learning-based prognostic model in head and neck cancer using the systemic inflammatory response index and correlations with patient reported financial toxicityAnurag Singh, Sung Jun Ma, Dukagjin Blakaj, et al.
Research Square|April 24, 2023
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapyScott Gerber, Taylor Uccello, Maggie Lesch, et al.
JAMA Network Open|April 15, 2022
Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck CancerSung Jun Ma, Han Yu, Michael Khan, et al.
JAMA Network Open|June 27, 2023
Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapySung Jun Ma, Michael Khan, Udit Chatterjee, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
Cell Stress & Chaperones|February 4, 2024
Stress biology: Complexity and multifariousness in health and diseaseMatthias P Mayer, Laura Blair, Gregory L Blatch, et al.
Pageof 3